Rare diseases
Investigational molecules
Locations
Back to Estonia144 clinical trials in Tartu, Estonia across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in EstoniaKliinilisedUuringud.ee(opens in a new tab)Study on the Effectiveness and Safety of Efgartigimod for Adults with Primary Sjögren's Syndrome
EstoniaStudy on the Effectiveness and Safety of ESK-001 and Apremilast for Patients with Moderate to Severe Plaque Psoriasis
EstoniaStudy on the Effects of LNA043 for Patients with Knee Osteoarthritis
EstoniaStudy on the Effects of AGA2118 for Postmenopausal Women with Osteoporosis
EstoniaStudy of sonelokimab injection in adults with active psoriatic arthritis who have not received biological DMARDs treatment before
EstoniaStudy on the Effects and Safety of Guselkumab for Patients with Active Psoriatic Arthritis
EstoniaStudy on the Effectiveness and Safety of CHF6001 DPI with Roflumilast for Patients with Chronic Obstructive Pulmonary Disease (COPD) and Chronic Bronchitis
EstoniaStudy on the Long-Term Safety and Efficacy of Nemolizumab for Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis
EstoniaStudy on the Effectiveness and Safety of Vibozilimod for Adults with Moderate to Severe Plaque Psoriasis
EstoniaStudy of Risankizumab vs. Placebo for Patients with Active Psoriatic Arthritis and Inadequate Response to DMARD Therapy
EstoniaStudy on the Effectiveness and Safety of Abatacept Biosimilar (DRL_AB) and Methotrexate for Patients with Moderate to Severe Rheumatoid Arthritis
EstoniaStudy on the Effectiveness and Safety of AVP-786 (Quinidine Sulfate and Deudextromethorphan Hydrobromide) for Treating Agitation in Alzheimer's Dementia Patients
EstoniaThe busiest research cities in the country
What the registry says about research in the country
Several trials focusing on innovative treatments for autoimmune disorders, particularly investigating new therapies for psoriatic arthritis and plaque psoriasis. Research includes testing of novel compounds like zasocitinib and evaluating long-term safety profiles.
Studies aim to improve disease management and patient outcomes through targeted therapies.
Comprehensive cancer research programs examining treatments for various types of lung cancer and other malignancies. Studies focus on combination therapies and novel treatment approaches.
Emphasis on immunotherapy combinations and targeted treatments for better patient outcomes.
Investigation of treatments for osteoporosis and related conditions, with a focus on postmenopausal women and innovative therapeutic approaches.
Research aims to improve bone health and manage metabolic conditions through new therapeutic options.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
